Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03651453 · ClinicalTrials.gov registry record · NA
OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings
A NA study of HIV Infections and Substance Abuse, sponsored by Yale University.
- Completed
- Registry status
- NA
- Development phase
- 164
- Enrollment target
- 1
- Study location
NCT03651453 is a NA study of HIV Infections and Substance Abuse that has completed, run by Yale University. The registered enrollment target is 164 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (63% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03651453, a NA study of HIV Infections and Substance Abuse, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- NA
- Development phase
- 164 participants
- Enrollment target
- 1
- Study location
Study Summary
To develop and test the effect of a patient-centered HIV prevention decision aid on HIV pre-exposure prophylaxis (PrEP) uptake among women with substance use disorders (SUD) in treatment.
Conditions Studied
Interventions
- BEHAVIORAL Standard care
- BEHAVIORAL Decision aid
Study Locations (1)
Connecticut
- Yale AIDS Program - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 164 participants |
| Start Date | 2018-10-15 |
| Est. Completion | 2020-06-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03651453
The ClinicalTrials.gov registry entry for NCT03651453 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 164 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (63% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with HIV Infections appearing as the primary indexed condition, and to 2 interventions - of which Standard care is the first listed.
NCT03651453 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT03651453 about?
NCT03651453 is a clinical study titled "OPTIONS: A Patient-Centered HIV Prevention Decision Aid for PrEP Uptake for Women With Substance Use in Treatment Settings". To develop and test the effect of a patient-centered HIV prevention decision aid on HIV pre-exposure prophylaxis (PrEP) uptake among women with substance use disorders (SUD) in treatment.
What is the current status of trial NCT03651453?
This trial is currently completed. It is a NA study. The enrollment target is 164 participants. The study started on 2018-10-15. Estimated completion is 2020-06-11.
What conditions does trial NCT03651453 study?
This clinical trial studies the following conditions: HIV Infections, Substance Abuse.
What interventions are being tested in trial NCT03651453?
The interventions under investigation include: Standard care (BEHAVIORAL), Decision aid (BEHAVIORAL).
Who is sponsoring clinical trial NCT03651453?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03651453 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for HIV Infections
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TRAC-ER Intervention to Reduce Risky Alcohol Use and HIV Risk
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
WiseApp for Spanish Speakers Living With HIV
RECRUITING · NA
-
Comprehensive HIV and Harm Prevention Via Telehealth
RECRUITING · NA
-
Substance Checking Outreach and Pre-Exposure Prophylaxis (PrEP) Engagement Study
RECRUITING · NA
-
Food as Medicine for HIV and Diabetes
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.